Menopause and Perimenopause Flashcards
Provider Role for Midlife Women
- Empower each woman to make healthy, positive life choices
- Assist women to assess her individual health status, strengths, risks, etc.
- Help each woman listen to her wisdom
- Provide updated, accurate information
- Advocate ongoing research issues facing women
Estrogen Functions
- Female sex characteristics
- 400+ receptor sites in body
- Increases NO, dilating blood vessels and mediating vasoactive effects of angiotensin
- Improves HDL, lowers total and LDL
- Improves CHO metabolism
- Mediates serotonin release and inhibits uptake of norepi
- Increases growth of new dendrites and new synapses
- Increases production of acetyltransferase leading to acetylcholine
- Inhibits MAO
- Regulates sleep centers
- Enhances concentration
- Maintains bone density, skin, and hair
Estrogens Native to Women (Bioidentical)
- Estrone (E1): Dominant post-menopausal
- Estradiol (E2): Dominant pre-menopausal; activates alpha and beta
- Estriol (E3): Highest in pregnancy; antagonizes stimulation by stimulating beta
- Estrogens effects by 2 mechanisms:
- Alpha: Promotes cell proliferation; may be contributing factors to some cancers
- Beta: Inhibits breast cell prolieration
Effects of Progesterone
- regulates menstrual flow
- Stabilizes lining o uterus to allow for implantation of embryo
- Decreases intestinal motility
- Bone building
- Calming, sedating
- Can balance estrogen
Effects of testosterone
- Enhances libido and mood
- Increases energy, lean body muscle, and bone density
- Decreases fat
Definition: Perimenopause
- Period of fluctuating hormonal changes 5-15yrs before menopause
Early Perimenopause
- Longer/heavier cycles
- Often more frequent
Late Perimenopause
- Skipped periods
- Shorter/lighter
Premature menopause
- <40yo
Early Menopause
- <45yo
Effects of Perimenopause on Cycles
- fertility decreases with age but birth control still essential
- High unintended pregnancy rate
- Impact on childbearing choices
- Fibroids: Effects on bleeding; only a problem if they cause bleeding or big enough to cause bulk symptoms or pressure
Balance upset in perimenopause
- Can be higher E2/lower P
- Can be lower E2/higher P
- Can have both low
- Testosterone becomes more dominant as E2 decreases -> can lead to increased acne, facial hair, ABD fat
Severity of symptoms from hormonal changes
- Rate of decline in hormones affects severity of symptoms
- Surgery vs. natural
Symptoms of decreased ovarian functions: Vasomotor Instability
- Caused by decreased estrogen
- Hot flashes (sensation)
- Hot flushes (redness, diaphoresis)
- Night sweats
- Palpitations
Symptoms of decreased ovarian functions: Sleep disruption
- Caused by decreased estrogen
- Leads to low serotonin
- Decreased REM sleep/deep sleep
Symptoms of decreased ovarian functions: Vaginal changes
- atrophy of skin
- decreased moisture
- dyspareunia
- pH more alkaline -> more UTIs
Symptoms of decreased ovarian functions: skin
- dryness
- sagging
- Increased central fat deposition
Symptoms of decreased ovarian functions: Mood
- Increased risk of depressive/anxiety symptoms
Symptoms of decreased ovarian functions: Others
- Fuzzy thinking
- Worsening PMS
- Energy level changes: up or down
- Sexual responses: decreased orgasmic response; increase or decrease libido
- joint pains/achiness
- Increased incontinence (may be due to general aging and obesity)
- decreased bone formation / increased resorption
- Increased cholesterol: Up LDL, Down HDL
- Increased BP
- Increased pain syndromes (fibromyalgia)
- Increased CAD
- Decreased muscle strength
Factors to consider in deciding whether to Rx HRT
- Know medical Hx: Breast Ca
- reasons for choosing
- balance risks and benefits
- make patients know all options
- doesn’t have to be right decision for always, may be reversed
Reasons to start HRT
- Symptoms relief
- Prevention/Attenuation of chronic Dz (cardiac, osteoporosis)
Definitions for HRT
- ERT or ET: Estrogen-replacement therapy
- EPT: combined estrogen/progesterone replacement
- HRT: any hormone at all
Bioidentical Hormones: Facts
- Exact copies of endogenous human hormone
- Does not mean not synthesized in lab
- Many confuse with term “natural”
- Natural may mean from a horse like premarin, from a source in ground, or bioidentical
- Does not have to come from compounding pharmacy
- Synthetic: different chemical structures or non-human versions (aka horse)
Bioidentical Estrogens (17-beta Estradiol)
- TD Patches: Vivelle-dot, Climara, Mylan (generic)
- TD Gels: Divigel, Estrogel, Elestin
- Topical spray mists: Evamist
- Topical lotion: Estrasorb
- Oral: Estrace, Estradiol (generic)
- Vaginal: Estrace cream, Estring ring (Vag dose), Femring (systemic dose), Vagifem pill
Compounding Pharmacy: Bioidentical estrogens
- 17b Estradiol oral, TD, vaginal
- Biestrin: Estradiol + estriol
- Estriol oral, TD, vaginal
- Subdermal pellets
Synthetic Estrogens
- Conjugated equine estrogens (CEE): Premarin (oral or vaginal only; NONE TD)
- Conjugated estrogens (Cenestin)
- Fem HRT: Ethinyl estradiol + northindrone; oral; all contraceptive estrogens contain this estrogen
Bioidentical Progesterone
- Regular pharmacies:
- Oral Prometrium (micronized natural progesterone; from peanut-oil; not for those with peanut allergies)
- Vaginal: Crinone
- From compounding pharmacies:
- Progesterone oral, TD, creams, vaginal
Synthetic Progestins
- Medroxyprogesterone acetate (MPA): provera
- Northindrone (mild)
- Levonorgestrel (stronger)
- Drospironone: Yaz, available with 17-b
- Norgestimate
Mixed Bioidentical/Synthetic Compounds
- Combined oral preps:
- Activella = Estradiol (17b) + northindrone
- Ortho Pre-Fest: estradiol + norgestimate
- Combined TD patches:
- Angelic: estradiol + Drospironone
- Climara Pro: estradiol + levonorgestrel
- CombiPatch: estradiol + northindrone
Sympomatic Benefits of HRT/ERT
- highly effective
- Decreased vasomotor symptoms
- Increased vaginal moisture, comfort, infections
- Improvement in sleep, mood
CVD in Women
- Leading cause of mortality in women
- Increase in women after menopause
- within 6yr after 1st MI, 35% will have another
- Higher fatality rate in 1st yr post-MI
HRT and CVD
- HRT decreases CVD by 35-50% in healthy women
- HRT are not helpful & probably harmful if already have CVD
- Do NOT use as primary or secondary prevention for CAD
Why increased risk in 1st yr after MI
- Without heart disease, estrogen:
- Decreases oxidation of LDL
- blood vessels dilate
- Inhibits development of atherosclerosis
- With underlying heart disease, estrogen:
- Induces inflammation in existing plaque
- Can cause stable plaque to rupture
- Can lead to blockage of artery
MPA and CAD
- MPA negates more of estrogen’s benefits on lipids
- Greater decrease in HDL
- Vasoconstriction vs. maintenance of vasodilation
- Promotes atherosclerotic plaque formation
- Can increase insulin resistance much more
HRT and Memory
- 40-60% decrease in risk of AD in women taking estrogen vs. never taken
- No benefit when used as treatment for AD, timing important
- Estrogen selectively improves executive function
HRT and Breast CA
- E + P = significant increase in risk (RR=1.25)
- No risk with E alone
- Bioidentical Progesterone may help risk as opposed to synthetic P, which increases risk
Estriol and Breast CA
- ER-alpha: Promotes proliferation
- ER-beta: inhibits proliferation
- Estradiol equally activates ER-a and ER-b
- Estriol binds ER-b in 3:1 ratio -> potential for breast CA prevention
- In cell cultures estriol acts as anti-estrogen if given with estradiol
HRT: Other risks
- OCPs decrease risk for ovarian cancer
- Gall bladder disease increased with oral E x3 over non-users
- Increased endometrial cancer 4-10x with unopposed E
- Oral E increases risk of VTE (still small)
- TD E has no increased risk for VTE
Possible side effects of HRT
- HA and nausea
- Mood worsening - especially with progestins
- Increased weight more with progestins, bloating
- Breast tenderness
- Irregular uterine bleeding
Progesterone vs. Provera
- Better QoL
- Fewer side effects in: depression; sleep problems; menstrual bleeding
Recommendations for HRT
- Complete H&P prior to use
- Mammography within previous 12mo
- Use primarily for moderate-to-severe symptoms
- Vaginal ET if solely for vaginal symptoms
- Consider EPT for osteoporosis risk reduction in high risk women
- Do NOT use ET/EPT for secondary CAD prevention
Change in 2010 recommendations
- ET may decrease CHD risk when initiated in younger and more recently menopausal
- 50-59: significant decrease in risk of MI and coronary death
- EPT significantly increases risk of CHD if started >10yrs after menopause; lower risk <10yrs after
Low-Dose OCPs in Perimenopause
- Helps regulate cycles
- Controls heavy bleeding
- Helps preserve and potentially build bone
- Alleviate symptoms
- Contraception
- Decreased risk of ovarian cancer
- Safe in non-smokers - can switch to HRT at 50yo
Different dose strength from HRT
How to use HRT
- Dosing: Oral, TD, Vaginal
- Cyclic vs. Continuous
- Estrogen: q day
- Progesterone: cyclical or continuous
Contraindications to EPT/ET
- Presence or suspicion of breast/endometrial cancer
- Hx of unexplained vaginal bleeding
- Hx of MI or stroke
- Active thrombosis/thrombophlebitis
- Known or suspected pregnancy
- Acute liver Dz
Screening Tests: Mammograms
- 40-50yo: Yearly (ACS) vs. q1-2yrs (CDC & ACOG)
- > 50yo: Yearly (ACOG/ACS); q2yr (USPSTF)
- Family Hx: Baseline at 35 or r/t age of Dx in family member
- > 20-25% risk of breast Ca: to breast clinical annual mammogram + MRI
Paps: 2012 Guidelines
- Regs. apply regardless of sexual Hx
- 21-65yo Cytology q 3yrs or if 30-65 and want to lengthen screening, can do cytology + HPV q5yr
- None >65 if 3 consecutive normal Pap or 2 consecutive negative HPV tests
- None after hysterectomy unless Hx of CIN 2, 3, or cervical Ca
- No HPV testing in <30yo, even reflex
Calcium
- may increase bone density
- decreased vertebral Fx
- Can slow rate of endogenous resorption
- 9-18yo 1200-1500mg
- 19-50yo: 1g
- > 50yo: 1200-1500mg
- Men: 800mg
- > 1500mg: limited benefit potential
- > 2g/d may increase risk of kidney stones
Vitamin D
- Enhances calcium absorption
- 50yo: 800-1000IU/d; kids: 400IU/d
- 1000-1200IU/d if at increased risk for deficiency
- Doses up to 2000IU/d considered safe
- If Vd deficiency: treat with D3 (Cholecalciferol) 50,000IU/wk x 3mo
Immunizations
- Flu q yr
- Tdap q 10yrs
- Pneumococcal X1 >65yo; If got one before 65, get one more at 65
- Zoster vaccine at age 60 x1
- Varicella x 2 doses if not immune
- Meningococcal x1 dose if at risk
- Hep A and Hep B if risk factors present
- MMR born >1956 - if not vaccinated need 1 dose; 2nd dose if health worker or international travel